SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-764437
Filing Date
2016-11-09
Accepted
2016-11-09 16:37:02
Documents
64
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d174318d10q.htm 10-Q 385050
2 EX-31.1 d174318dex311.htm EX-31.1 6775
3 EX-31.2 d174318dex312.htm EX-31.2 6992
4 EX-32.1 d174318dex321.htm EX-32.1 5282
  Complete submission text file 0001193125-16-764437.txt   3650726

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT zsan-20160930.xml EX-101.INS 684751
6 XBRL TAXONOMY EXTENSION SCHEMA zsan-20160930.xsd EX-101.SCH 46672
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE zsan-20160930_cal.xml EX-101.CAL 61760
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE zsan-20160930_def.xml EX-101.DEF 193396
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE zsan-20160930_lab.xml EX-101.LAB 407826
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zsan-20160930_pre.xml EX-101.PRE 278897
Mailing Address 34790 ARDENTECH COURT FREMONT CA 94555
Business Address 34790 ARDENTECH COURT FREMONT CA 94555 510-745-1200
Zosano Pharma Corp (Filer) CIK: 0001587221 (see all company filings)

IRS No.: 454488360 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36570 | Film No.: 161984742
SIC: 2834 Pharmaceutical Preparations